Outlook of Mergers & Acquisitions, Investments, and Patents in the 3D Printing Market (2010–2016)

The 3D printing market has witnessed tremendous growth in M&A activities in terms of the number of deals announced between 2010 and 2016.

Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015

GlobalData’s clinical trial report, “Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015″” provides an overview of Patent Ductus Arteriosus clinical trials scenario. This report provides top line data relating to the clinical trials on Patent Ductus Arteriosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency prevents insulin-sensitive cells from carrying out essential glucose metabolism and leads to hyperglycemia (high blood glucose levels).

Analysis of China’s Pesticide Innovation and Global Coming Off-patent Pesticides

China can produce more than 6,000 kinds of pesticides, among them, more than 300 are commonly used. However, China only has about 50 innovative pesticides, and none of them has large market share and high reputation in both domestic and foreign market. In the aspect of pesticide patent application,

China’s Guidebook for Pharmaceutical Patent Protection

“China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) reported by the «2012: Report of China Pharmaceutical Market» published by Chinese Academy of Social Sciences.